Cramer Says Doximity Has Right Prescription, and the Charts Agree

We don't have a lot of price history, but what we do see is bullish for DOCS.

Ventas Looks Stagnant for Now But Could See Shares Rise Later This Year

The technical signs of the provider of senior housing are mixed at present.

3 Healthcare Stocks for 3%+ Dividend Yields

These picks are attractive for value-oriented dividend investors looking for strong current income potential.

For Now, Moderna Is an Options Play For Me

The shares are only trading at 17 times forward earnings, and might not be fully valued just yet.

Moderna Flashes Signs of an Interim Top

The charts of the vaccine maker indicate it's a good time to take some profits or raise stops, or both.

Pfizer Price Targets? I've Got Them for You

A subscriber asks. We answer.

Veru Is Pointed Lower Now

Charts suggest there could be further downside risk.

Jim Cramer: Let's Give Taiwan a Needed Shot in the Arm

Here's how the U.S. can play a critical part in defending the island from COVID -- and mainland China.

Is Pfizer Ready to Make an Upside Breakout?

Traders could go long PFE at current levels and here's where they can add to longs.

GoodRx Isn't Showing Us a Good Stock Chart

Avoid the long side of GDRX until we see evidence of a durable bottom.